chr13:32907411:CTTAT> Detail (hg19) (BRCA2)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr13:32,907,411-32,907,415 |
hg38 | chr13:32,333,274-32,333,278 |
HGVS
Type | Transcript | Protein |
---|---|---|
RefSeq | NM_000059.3:c.1796_1800delCTTAT | NP_000050.2:p.Ser599Ter |
Ensemble | ENST00000700202.2:c.1796_1800delCTTAT | ENST00000700202.2:p.Ser599Ter |
ENST00000713678.1:c.1796_1800delCTTAT | ENST00000713678.1:p.Ser599Ter |
Summary
MGeND
Clinical significance | |
Variant entry | |
GWAS entry | |
Disease area statistics | Show details |
Frequency
JP | HGVD:[No Data.] |
ToMMo:<0.001 | |
NCBN:[No Data.] | |
NCBN(Hondo):[No Data.] | |
NCBN(Ryukyu):[No Data.] | |
East asia | ExAC:[No Data.] |
Prediction
ClinVar
Clinical Significance |
![]() |
Review star | ![]() |
Show details |
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
Clinical significance | Last evaluated | Review status | Condition | Origin | Links |
---|---|---|---|---|---|
![]() |
2016-04-22 | reviewed by expert panel | Breast-ovarian cancer, familial, susceptibility to, 2 |
![]() ![]() |
Detail |
![]() |
2023-05-11 | criteria provided, multiple submitters, no conflicts | not provided |
![]() ![]() |
Detail |
![]() |
2022-03-09 | criteria provided, multiple submitters, no conflicts | Hereditary cancer-predisposing syndrome |
![]() |
Detail |
![]() |
2024-01-12 | criteria provided, multiple submitters, no conflicts | hereditary breast ovarian cancer syndrome |
![]() |
Detail |
![]() |
no assertion criteria provided |
![]() |
Detail | ||
![]() |
2021-07-14 | criteria provided, single submitter | Wilms tumor 1,Pancreatic cancer, susceptibility to, 2,Malignant tumor of prostate,medulloblastoma,Breast-ovarian cancer, familial, susceptibility to, 2,Familial cancer of breast,Glioma susceptibility 3,Fanconi anemia complementation group D1 |
![]() |
Detail |
![]() |
2021-07-14 | criteria provided, single submitter | Wilms tumor 1,Pancreatic cancer, susceptibility to, 2,Malignant tumor of prostate,medulloblastoma,Breast-ovarian cancer, familial, susceptibility to, 2,Familial cancer of breast,Glioma susceptibility 3,Fanconi anemia complementation group D1 |
![]() |
Detail |
![]() |
2021-07-14 | criteria provided, single submitter | Wilms tumor 1,Pancreatic cancer, susceptibility to, 2,Malignant tumor of prostate,medulloblastoma,Breast-ovarian cancer, familial, susceptibility to, 2,Familial cancer of breast,Glioma susceptibility 3,Fanconi anemia complementation group D1 |
![]() |
Detail |
![]() |
2021-07-14 | criteria provided, single submitter | Wilms tumor 1,Pancreatic cancer, susceptibility to, 2,Malignant tumor of prostate,medulloblastoma,Breast-ovarian cancer, familial, susceptibility to, 2,Familial cancer of breast,Glioma susceptibility 3,Fanconi anemia complementation group D1 |
![]() |
Detail |
![]() |
2021-07-14 | criteria provided, single submitter | Wilms tumor 1,Pancreatic cancer, susceptibility to, 2,Malignant tumor of prostate,medulloblastoma,Breast-ovarian cancer, familial, susceptibility to, 2,Familial cancer of breast,Glioma susceptibility 3,Fanconi anemia complementation group D1 |
![]() |
Detail |
![]() |
2021-07-14 | criteria provided, single submitter | Wilms tumor 1,Pancreatic cancer, susceptibility to, 2,Malignant tumor of prostate,medulloblastoma,Breast-ovarian cancer, familial, susceptibility to, 2,Familial cancer of breast,Glioma susceptibility 3,Fanconi anemia complementation group D1 |
![]() |
Detail |
![]() |
2021-07-14 | criteria provided, single submitter | Wilms tumor 1,Pancreatic cancer, susceptibility to, 2,Malignant tumor of prostate,medulloblastoma,Breast-ovarian cancer, familial, susceptibility to, 2,Familial cancer of breast,Glioma susceptibility 3,Fanconi anemia complementation group D1 |
![]() |
Detail |
![]() |
2021-07-14 | criteria provided, single submitter | Wilms tumor 1,Pancreatic cancer, susceptibility to, 2,Malignant tumor of prostate,medulloblastoma,Breast-ovarian cancer, familial, susceptibility to, 2,Familial cancer of breast,Glioma susceptibility 3,Fanconi anemia complementation group D1 |
![]() |
Detail |
![]() |
2023-05-13 | criteria provided, single submitter | Familial cancer of breast |
![]() |
Detail |
![]() |
2024-02-14 | criteria provided, single submitter | BRCA2-related disorder |
![]() |
Detail |
CIViC
[No Data.]
DisGeNET
Score | Disease name | Description | Source | Pubmed | Links |
---|---|---|---|---|---|
0.240 | Breast-ovarian cancer, familial, susceptibility to, 2 | NA | CLINVAR | Detail | |
0.174 | Breast Cancer, Familial | NA | CLINVAR | Detail | |
0.391 | Hereditary Breast and Ovarian Cancer Syndrome | NA | CLINVAR | Detail | |
0.128 | Neoplastic Syndromes, Hereditary | NA | CLINVAR | Detail |
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
NM_000059.4(BRCA2):c.1796_1800del (p.Thr598_Ser599insTer) AND Breast-ovarian cancer, familial, susce... | ClinVar | Detail |
NM_000059.4(BRCA2):c.1796_1800del (p.Thr598_Ser599insTer) AND not provided | ClinVar | Detail |
NM_000059.4(BRCA2):c.1796_1800del (p.Thr598_Ser599insTer) AND Hereditary cancer-predisposing syndrom... | ClinVar | Detail |
NM_000059.4(BRCA2):c.1796_1800del (p.Thr598_Ser599insTer) AND Hereditary breast ovarian cancer syndr... | ClinVar | Detail |
NM_000059.4(BRCA2):c.1796_1800del (p.Thr598_Ser599insTer) AND Malignant tumor of breast | ClinVar | Detail |
NM_000059.4(BRCA2):c.1796_1800del (p.Thr598_Ser599insTer) AND multiple conditions | ClinVar | Detail |
NM_000059.4(BRCA2):c.1796_1800del (p.Thr598_Ser599insTer) AND multiple conditions | ClinVar | Detail |
NM_000059.4(BRCA2):c.1796_1800del (p.Thr598_Ser599insTer) AND multiple conditions | ClinVar | Detail |
NM_000059.4(BRCA2):c.1796_1800del (p.Thr598_Ser599insTer) AND multiple conditions | ClinVar | Detail |
NM_000059.4(BRCA2):c.1796_1800del (p.Thr598_Ser599insTer) AND multiple conditions | ClinVar | Detail |
NM_000059.4(BRCA2):c.1796_1800del (p.Thr598_Ser599insTer) AND multiple conditions | ClinVar | Detail |
NM_000059.4(BRCA2):c.1796_1800del (p.Thr598_Ser599insTer) AND multiple conditions | ClinVar | Detail |
NM_000059.4(BRCA2):c.1796_1800del (p.Thr598_Ser599insTer) AND multiple conditions | ClinVar | Detail |
NM_000059.4(BRCA2):c.1796_1800del (p.Thr598_Ser599insTer) AND Familial cancer of breast | ClinVar | Detail |
NM_000059.4(BRCA2):c.1796_1800del (p.Thr598_Ser599insTer) AND BRCA2-related disorder | ClinVar | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- dbSNP
- rs276174813 dbSNP
- Genome
- hg19
- Position
- chr13:32,907,411-32,907,415
- Variant Type
- snv
- Reference Allele
- CTTAT
- Alternative Allele
- -
- ToMMo VCF FILTER column value (ToMMo 8.3KJPN Allele Frequency Panel(v20200831))
- PASS
- Total VCF ID column value (ToMMo 8.3KJPN Allele Frequency Panel(v20200831))
- rs276174813
- Allele frequency, for each ALT allele (ToMMo 8.3KJPN Allele Frequency Panel(v20200831))
- 0.0001
- Allele count in genotypes, for each ALT allele (ToMMo 8.3KJPN Allele Frequency Panel(v20200831))
- 1
- Total number of alleles in called genotypes (ToMMo 8.3KJPN Allele Frequency Panel(v20200831))
- 16760
Genome browser